1. Moen MH, Magnus P. The familial risk of endometriosis. Acta Obstet Gynecol Scand1993;72:560-564.
2.
2. Matalliotakis IM, Goumenou AG, Koumantakis GE, et al. Expression of serum human leukocyte antigen and growth factor levels in a Greek family with familial endometriosis. J Soc Gynecol Investig2003;10:118-121.
3.
3. Simpson JL, Malinak LR, Elias S, et al. HLA asociations in endometriosis. Am J Obster Gynecol1984;148:395-397.
4.
4. Moen M, Bratlie A, Moen T. Distribution of HLA-antigens among patients with endometriosis. Acta Obstet Gynecol Scand1984;123(Suppl):25-27.
5.
5. Verbruggen LA, Dumarey N, Van de Velde H, et al. Soluble HLA-DR antigen levels in serum correlate with rheumatoid arthritis disease activity and the presence of disease-associated epitopes. Tissue Antigens2000;56:436-440.
6.
6. Bresciani A, Pirozzi G, Spera M, et al. Increased level of serum HLA class I antigens in patients with systemic lupus in patients with systemic lupus erythematosus. Correlation with disease activity. Tissue Antigens1998;52:44-50.
7.
7. Rong R, Ramachandran S, Santanam N, et al. Induction of monocyte chemotactic protein-1 in peritoneal mesothelial and endometrial cells by oxidized low-density lipoprotein and peritoneal fluid from women with endometriosis. Fertil Steril2002;78:843-848.
8.
8. Shifren JL, Tseng JF, Zaloudek CJ, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab1996;81:3112-3118.
9.
9. Tan XJ, Lang JH, Liu DY, et al. Expression of vascular endothelial growth factor and thrombospondin-1 mRNA in patients with endometriosis. Fertil Steril2002;78:148-153.
10.
10. Lebovic DI, Bentzien F, Chao VA, et al. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1beta. Mol Hum Reprod2000;6:269-275.
11.
11. Ben-Av P, Crofford LJ, Wilder RL, et al. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis. FEBS Lett1995;372:83-87.
